A phase II study of milataxel: a novel taxane analogue in previously treated patients with advanced colorectal cancer

被引：0
|
作者：
Ramesh K. Ramanathan
Joel Picus
Haralambos Raftopoulos
Stephen Bernard
A. Craig Lockhart
Gary Frenette
John Macdonald
Susan Melin
Daniel Berg
Frank Brescia
Howard Hochster
Allen Cohn
机构：
[1] University of Pittsburgh School of Medicine,Division of Hematology/Oncology, Department of Medicine
[2] Washington School of Medicine,Department of Internal Medicine, Division of Hematology/Oncology
[3] Columbia University Medical Center,undefined
[4] University of North Carolina,undefined
[5] Chapel Hill,undefined
[6] Vanderbilt University Medical Center,undefined
[7] Carolinas Hematology–Oncology Associates,undefined
[8] Saint Vincent’s Comprehensive Cancer Center,undefined
[9] Aptium Oncology,undefined
[10] Wake Forest University,undefined
[11] University of Iowa,undefined
[12] Medical University of South Carolina,undefined
[13] New York University School of Medicine,undefined
[14] Rocky Mountain Cancer Center,undefined
[15] UPMC Cancer Pavilion,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词：
Colorectal cancer; Phase II; Milataxel; MAC-321; Taxanes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：453 / 458
页数：5
相关论文
共 50 条
  • [11] Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study
    Suenaga, Mitsukuni
    Mizunuma, Nobuyuki
    Matsusaka, Satoshi
    Shinozaki, Eiji
    Ozaka, Masato
    Ogura, Mariko
    Yamaguchi, Toshiharu
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 3099 - 3108
  • [12] Phase II study of regorafenib (Reg) in patients with previously treated advanced pancreatic cancer (APC).
    Salmon, John Stuart
    Hwang, Jimmy J.
    Robinson, Myra M.
    Symanowski, James Thomas
    Dillon, Lloye M.
    Das Roy, Lopamudra
    Beldner, Matthew A.
    Preston, Kelry
    Buige, Sharon
    Nazemzadeh, Reza
    Mukherjee, Pinku
    Farhangfar, Farhang
    Kim, Edward S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [13] A phase II study of tivantinib monotherapy in patients with previously treated advanced or recurrent gastric cancer
    Muro, Kei
    Ryu, Min-Hee
    Yasui, Hirofumi
    Nishina, Tomohiro
    Ryoo, Baek-Yeol
    Boku, Narikazu
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [14] PHASE-II STUDY OF DON IN PATIENTS WITH PREVIOUSLY TREATED ADVANCED LUNG-CANCER
    EAGAN, RT
    FRYTAK, S
    NICHOLS, WC
    CREAGAN, ET
    INGLE, JN
    CANCER TREATMENT REPORTS, 1982, 66 (08): : 1665 - 1666
  • [15] PHASE II STUDY OF A NOVEL TAXANE (CABAZITAXEL-XRP 6258) IN PREVIOUSLY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS: TOXICITY REPORT
    Bordoni, Rodolfo
    Robert, Francisco
    Saleh, Mansoor
    Dixon, Pamela
    Howell, Barbara
    Griffith, Candice
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1181 - S1181
  • [16] A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen
    Lida Mina
    Ian Krop
    Robin T. Zon
    Steven J. Isakoff
    Charles J. Schneider
    Menggang Yu
    Cindy Johnson
    LaTrice G. Vaughn
    Yanping Wang
    Maria Hristova-Kazmierski
    Oluwatoyin O. Shonukan
    George W. Sledge
    Kathy D. Miller
    Investigational New Drugs, 2009, 27 : 565 - 570
  • [17] A phase II study of oral enzastaurin in patients with metastatic breast cancer previously treated with an anthracycline and a taxane containing regimen
    Mina, Lida
    Krop, Ian
    Zon, Robin T.
    Isakoff, Steven J.
    Schneider, Charles J.
    Yu, Menggang
    Johnson, Cindy
    Vaughn, LaTrice G.
    Wang, Yanping
    Hristova-Kazmierski, Maria
    Shonukan, Oluwatoyin O.
    Sledge, George W.
    Miller, Kathy D.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (06) : 565 - 570
  • [18] Phase II Study of the Halichondrin B Analog Eribulin Mesylate in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane, and Capecitabine
    Cortes, Javier
    Vahdat, Linda
    Blum, Joanne L.
    Twelves, Chris
    Campone, Mario
    Roche, Henri
    Bachelot, Thomas
    Awada, Ahmad
    Paridaens, Robert
    Goncalves, Anthony
    Shuster, Dale E.
    Wanders, Jantien
    Fang, Fang
    Gurnani, Renuka
    Richmond, Elaine
    Cole, Patricia E.
    Ashworth, Simon
    Allison, Mary Ann
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (25) : 3922 - 3928
  • [19] POSITIVE PHASE-II STUDY OF DIBROMODULCITOL (DBD) IN PREVIOUSLY TREATED PATIENTS WITH ADVANCED COLORECTAL-CARCINOMA
    BIERMANN, WA
    CATALANO, RB
    ENGSTROM, PF
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 373 - 373
  • [20] Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer
    Reddy, S. M.
    Kopetz, S.
    Morris, J.
    Parikh, N.
    Qiao, W.
    Overman, M. J.
    Fogelman, D.
    Shureiqi, I.
    Jacobs, C.
    Malik, Z.
    Jimenez, C. A.
    Wolff, R. A.
    Abbruzzese, J. L.
    Gallick, G.
    Eng, C.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (04) : 977 - 984
12345